ACB Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Aurora Cannabis, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 1. Aurora cannabis medizinisches cannabis cannimed tse: acb, cannabis, Winkel, Bereich png. aurora cannabis medizinisches cannabis cannimed tse: acb. AURORA CANNABIS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Aurora Cannabis | A2P4EC | ACB | CAX
Aurora Cannabis Inc (ACB)Aurora cannabis medizinisches cannabis cannimed tse: acb, cannabis, Winkel, Bereich png. aurora cannabis medizinisches cannabis cannimed tse: acb. medizinisches cannabis aurora cannabis cannimed tetrahydrocannabinol, hanf, Bereich, Aurora Cannabis png xpx KB; Medizinisches. ACB Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Aurora Cannabis, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 1.
Tse:Acb Other Services VideoAurora Cannabis Inc (TSE:ACB) Cannabis Bigger Than Booze
Montreal Exchange. Toronto Stock Exchange. TSX Venture Exchange. TSX Alpha Exchange. Top Price Performer. Stocks that have outperformed the market.
ROE Leader. Stocks with the highest Return on Equity. Rising Stars. The company received its license to grow cannabis in , making it the first cannabis producer to obtain a federal license in that province.
Since then they have built, and are operating, numerous growing facilities throughout Canada, Europe, Asia, Latin America and Oceania.
Canada legalized the retail sale of cannabis nationally on October 17, Aurora grew through several acquisitions.
By , Aurora's subsidiaries included Pedanios GmbH Germany 's largest distributor of cannabis to pharmacies ,  CanvasRx the largest medical cannabis patient outreach service in Canada ,  BC Northern Lights an indoor growing supplies manufacturer ,  Aurora-Larssen Projects a globally leading greenhouse engineering and design consultancy ,  and H2 Biopharma a late-stage ACMPR applicant in Quebec .
A report in mid-September by BNN Bloomberg, stated that Coca-Cola was considering the development of cannabis-infused beverages for medical purposes with a non-psychoactive ingredient, CBD and was in preliminary discussion with Aurora.
Although Coke and Aurora then announced that they were merely studying the market, and had no plan to announce regarding the distribution of such products.
A major issue has been the Aurora's focus on premium cannabis which is more expensive for consumers. During the fourth quarter of , several law firms in the United States announced class action lawsuits against Aurora, citing the abrupt decline in stock price, failure to complete planned capital investments, and missed revenue and profit forecasts by the company as misleading to public investors.
During an interview in November , CEO Terry Booth discussed the poor retail performance of the Canadian cannabis industry, saying that "carnage" was possible unless certain producers were able to reduce the cost of operations when oversupply existed.
This was part of the goal to "reduce its expenses and boost its cash balance after a series of weak quarters," according to a news report.
Aurora owns Pedanios GmbH, a wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Berlin, Germany.
Pedanios is the EU's largest distributor of cannabis by volume of product sold. As of March , it is one of three distributors to offer cannabis flowers sourced from both Canada and the Netherlands.
In January, , Aurora became the first private company to be granted a supply agreement to the Italian market through its German subsidiary Pedanios.
A statement from the company in early October reported a funding capacity for over , kg of cannabis per year, with sales and operations in 25 countries.
On November 13, , Aurora Cannabis delivered an all-stock takeover bid to CanniMed Therapeutics 's board of directors, which became public on November Market Cap — Basic —.
Number of Employees —. Number of Shareholders —. Balance Sheet. Current Ratio, FQ —. Debt to Equity, FQ —. Net Debt, FQ —. Quick Ratio, FQ —. Total Assets, FQ —.
Total Debt, FQ —. Operating Metrics. Return on Assets, TTM —. Return on Equity, TTM —. Revenue per Employee, TTM —. It's packed with all of the company's key stats and salient decision making information.
The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank Agreement, Magnitude, Upside and Surprise ; provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock.
Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Learn more about Zacks Equity Research reports.
See more Zacks Equity Research reports. I accept X. If you wish to go to ZacksTrade, click OK.Key Data. Volume 55, Market Cap 1. TSX Venture Exchange. All Analysts. Donat Wasser more about Zacks Equity Research reports.